mRNA vaccines — a new era in vaccinology

Pardi, Norbert, Hogan, Michael J., Porter, Frederick W., Weissman, Drew·2018·Nature Reviews Drug Discovery

Cited by (1,011)

Items 801–900 of 1,011

  1. Ribozyme Assays to Quantify the Capping Efficiency of In Vitro-Transcribed mRNA
    Irena Vlatkovic, János Ludwig, Gábor Boros, Gábor Tamás Szabó, Julia Reichert, Maximilian C. R. Buff, Markus Baiersdörfer, Jonas Reinholz, Azita J. Mahiny, Uğur Şahin et al. · 2022 · Pharmaceutics
  2. Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy
    Prajeena Karmacharya, Basavaraj Rudragouda Patil, Jong Oh Kim · 2022 · Journal of Pharmaceutical Investigation
  3. Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex
    Chapin S. Korosec, Suzan Farhang‐Sardroodi, David W. Dick, Sameneh Gholami, Mohammad Sajjad Ghaemi, Iain R. Moyles, Morgan Craig, Hsu Kiang Ooi, Jane Marie Heffernan · 2022 · Scientific Reports
  4. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses
    Ye Zeng, Oscar Escalona-Rayo, Renzo A. Knol, Alexander Kros, Bram Slütter · 2022 · Biomaterials Science
  5. An Overview of the Use of Nanoparticles in Vaccine Development
    Daniel Lozano, Vicente Larraga, María Vallet‐Regí, Miguel Manzano · 2023 · Nanomaterials
  6. Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity
    Niubing Zhang, Xiang Cheng, Yilong Zhu, Ouyang Mo, Huiqing Yu, Liqi Zhu, Juan Zhang, Linlin Kuang, Ying Gao, Ruiyuan Cao et al. · 2023 · Science China Life Sciences
  7. Revolutionising health care: Exploring the latest advances in medical sciences
    Gehendra Mahara, Cuihong Tian, Xiaojia Xu, Wei Wang · 2023 · Journal of Global Health
  8. Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery
    Qimanguli Saiding, Zhongyang Zhang, Shuying Chen, Fan Xiao, Yumeng Chen, Yongjiang Li, Xueyan Zhen, Muhammad Muzamil Khan, Wei Chen, Seyoung Koo et al. · 2023 · Advanced Drug Delivery Reviews
  9. The Constitutional Isomerism of One-Component Ionizable Amphiphilic Janus Dendrimers Orchestrates the Total and Targeted Activities of mRNA Delivery
    Dipankar Sahoo, Elena N. Atochina‐Vasserman, Devendra S. Maurya, Mahwish Arshad, Srijay S. Chenna, Nathan A. Ona, Jessica A. Vasserman, Houping Ni, Drew Weissman, Virgil Percec · 2024 · Journal of the American Chemical Society
  10. Biodegradable Lipid-Modified Poly(Guanidine Thioctic Acid)s: A Fortifier of Lipid Nanoparticles to Promote the Efficacy and Safety of mRNA Cancer Vaccines
    Kai Yang, Bing Bai, Jiaqi Lei, Xinyang Yu, Shaolong Qi, Yangfan Wang, Feihe Huang, Zaizai Tong, Guocan Yu · 2024 · Journal of the American Chemical Society
  11. mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo
    Qiannan Cao, Huapan Fang, Huayu Tian · 2024 · Biomaterials
  12. Functional probes for the diagnosis and treatment of infectious diseases
    Zhijin Fan, Yan Liu, Yuyun Ye, Yuhui Liao · 2024 · Aggregate
  13. Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice
    Jagger, Brett W, Dowd, Kimberly A, Chen, Rita E, Desai, Pritesh, Foreman, Bryant, Burgomaster, Katherine E, Himansu, Sunny, Kong, Wing-Pui, Graham, Barney S, Pierson, Theodore C et al. · 2019 · The Journal of Infectious Diseases
  14. A review on Promising vaccine development progress for COVID-19 disease
    Tafere Mulaw Belete · 2020 · Vacunas
  15. COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response
    Swati Jain, Himanshu Batra, Poonam Yadav, Subhash Chand · 2020 · Vaccines
  16. RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer
    Sakib Haque, Kiri A. Cook, Gaurav Sahay, Conroy Sun · 2021 · Pharmaceutics
  17. An overview of progress from empirical to rational design in modern vaccine development, with an emphasis on computational tools and immunoinformatics approaches
    Safoura Soleymani, Amin Tavassoli, Mohammad Reza Housaindokht · 2021 · Computers in Biology and Medicine
  18. A scalable and robust cationic lipid/polymer hybrid nanoparticle platform for mRNA delivery
    Randall A. Meyer, G. Patrick Hussmann, Norman C. Peterson, José Luís Santos, Anthony D. Tuesca · 2021 · International Journal of Pharmaceutics
  19. Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments
    Niaz Mahmud, Muzahidul Islam Anik, M. Khalid Hossain, Md Ishak Khan, Shihab Uddin, Md. Ashrafuzzaman, Md Mushfiqur Rahaman · 2022 · ACS Applied Bio Materials
  20. Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development
    Changwu Wu, Chaoying Qin, Wenyong Long, Xiangyu Wang, Kai Xiao, Qing Liu · 2022 · Journal Of Big Data
  21. Recent progress in application of nanovaccines for enhancing mucosal immune responses
    Guangsheng Du, Ming Qin, Xun Sun · 2022 · Acta Pharmaceutica Sinica B
  22. The Power of Field-Flow Fractionation in Characterization of Nanoparticles in Drug Delivery
    Juan Bian, Nemal S. Gobalasingham, Anatolii A. Purchel, Jessica Lin · 2023 · Molecules
  23. Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid delivery
    Lingxiao Xu, Zhenxuan Shao, Xia Fang, Zengfeng Xin, Shenzhi Zhao, Hongbo Zhang, Yu Zhang, Wenbiao Zheng, Xiaohua Yu, Zengjie Zhang et al. · 2024 · Exploration
  24. Rational Design of Lipid Nanoparticles for Enhanced mRNA Vaccine Delivery via Machine Learning
    Seo‐Hyeon Bae, Hosam Choi, Jisun Lee, Min‐Ho Kang, Seong‐Ho Ahn, Yu‐Sun Lee, Huijeong Choi, Sohee Jo, Yeeun Lee, Hyo‐Jung Park et al. · 2024 · Small
  25. Nanoparticles versus Dendritic Cells as Vehicles to Deliver mRNA Encoding Multiple Epitopes for Immunotherapy
    Rebuma Firdessa-Fite, Rémi J. Creusot · 2019 · Molecular Therapy — Methods & Clinical Development
  26. mRNA vaccines: a new era in vaccine development
    Shubhra Chandra, Jennifer C Wilson, David M. Good, Ming Qian Wei · 2024 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  27. A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation
    Kimura, Taishi, Leal, Joseph M., Simpson, Adrian, Warner, Nikole L., Berube, Bryan J., Archer, Jacob F., Park, Stephanie, Kurtz, Ryan, Hinkley, Troy, Nicholes, Katrina et al. · 2023 · Molecular Therapy
  28. The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy
    Akhil Shukla, Maryse Cloutier, Madanraj Appiya Santharam, Sheela Ramanathan, Subburaj Ilangumaran · 2021 · International Journal of Molecular Sciences
  29. Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results
    Andrea Lombardi, Giorgio Bozzi, Riccardo Ungaro, Simone Villa, Valeria Castelli, Davide Mangioni, Antonio Muscatello, Andrea Gori, Alessandra Bandera · 2021 · Frontiers in Immunology
  30. Coronavirus disease 2019 (COVID‐19) vaccines: A concise review
    Lakshman Perera Samaranayake, Chaminda Jayampath Seneviratne, Kausar Sadia Fakhruddin · 2021 · Oral Diseases
  31. COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
    Giuseppe Novelli, Michela Biancolella, Ruty Mehrian‐Shai, Vito Luigi Colona, Anderson Fernandes Brito, Nathan D. Grubaugh, Vasilis Vasiliou, Lucio Luzzatto, Juergen K. V. Reichardt · 2021 · Human Genomics
  32. Nanomedicine for The Poor: A Lost Cause or An Idea Whose Time Has Yet to Come?
    Vuk Uskoković · 2021 · Nanomedicine
  33. Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells
    Timo Burster, Rebecca Traut, Zhanerke Yermekkyzy, Katja Mayer, Mike‐Andrew Westhoff, Joachim Bischof, Uwe Knippschild · 2021 · Frontiers in Cell and Developmental Biology
  34. Transdermal delivery for gene therapy
    Parbeen Singh, I’jaaz Muhammad, Nicole E. Nelson, Khanh T. M. Tran, Tra Vinikoor, Meysam T. Chorsi, Ethan D’Orio, Thanh Duc Nguyen · 2022 · Drug Delivery and Translational Research
  35. Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors
    Cheng Huang, Xing Duan, Jichao Wang, Qingqing Tian, Yangmei Ren, Kepan Chen, Zongliang Zhang, Yuanyou Li, Yunyu Feng, Kunhong Zhong et al. · 2022 · Advanced Science
  36. Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment
    Yonglong He, Wanting Zhang, Qingqing Xiao, Lifang Fan, Dechun Huang, Wei Chen, Wei He · 2022 · Asian Journal of Pharmaceutical Sciences
  37. Strategies for Prevention and Control of Vibriosis in Asian Fish Culture
    Kangping Xu, Yushu Wang, Wangxiaohan Yang, Hongyan Cai, Youyu Zhang, Lixing Huang · 2022 · Vaccines
  38. Dendrimer-Mediated Delivery of DNA and RNA Vaccines
    L. A. Kisakova, Evgeny K. Apartsin, L. F. Nizolenko, Л. И. Карпенко · 2023 · Pharmaceutics
  39. Analyzing immune responses to varied mRNA and protein vaccine sequences
    Hyeong-Jun Park, Yoo‐Jin Bang, Sung Pil Kwon, Woori Kwak, Sang‐In Park, Gahyun Roh, Seo‐Hyeon Bae, Jaeyong Kim, Hye Won Kwak, Yongkwan Kim et al. · 2023 · npj Vaccines
  40. — Invited Review — Current status, challenges and prospects for pig production in Asia
    Lu Wang, Defa Li · 2024 · Animal Bioscience
  41. Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity
    Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, Akimasa Hayashi, Theofilus A. Tockary, Yuki Mochida, Shiro Akinaga, Michinori Kohara, Kazunori Kataoka, Satoshi Uchida · 2024 · Molecular Therapy
  42. Emerging Concepts of Nanobiotechnology in mRNA Delivery
    Yue Wang, Chengzhong Yu · 2020 · Angewandte Chemie International Edition
  43. Polymeric Micelles in Cancer Immunotherapy
    Zhuoya Wan, Ruohui Zheng, Pearl Moharil, Yuzhe Liu, Jing Chen, Runzi Sun, Xu Song, Qiang Ao · 2021 · Molecules
  44. Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response
    Phuong Quoc Thuc Nguyen, Mark Y. Sangster, David J. Topham · 2021 · Pathogens
  45. The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
    Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, Luis Alberto Breda Mascarenhas, Leone Peter Correia da Silva Andrade, Vinícius Pinto Costa Rocha, Milena Botelho Pereira Soares, Peter Berglund, Malcolm S. Duthie, Steven G. Reed et al. · 2021 · Vaccines
  46. Revisiting the Development of Vaccines Against Pathogenic Leptospira: Innovative Approaches, Present Challenges, and Future Perspectives
    Giovana Cappio Barazzone, Aline F. Teixeira, Bruna O. P. Azevedo, Deborah K. Damiano, Marcos P. Oliveira, Ana L. T. O. Nascimento, Alexandre P. Y. Lopes · 2022 · Frontiers in Immunology
  47. Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials
    Fatemeh Oroojalian, Ali Haghbin, Behzad Baradaran, Nima Hemmat, Mohammad‐Ali Shahbazi, Hossein Bannazadeh Baghi, Ahad Mokhtarzadeh, Michael Richard Hamblin · 2020 · International Journal of Biological Macromolecules
  48. 20 Post‐COVID‐19 vaccine‐related shingles cases seen at the Las Vegas Dermatology clinic and sent to us via social media
    Cynthia Lee, David Cotter, Jasmine Basa, Harry L. Greenberg · 2021 · Journal of Cosmetic Dermatology
  49. Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development
    Jie Liang, Xiao Zhao · 2021 · Cancer Biology and Medicine
  50. Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma
    Quanwei Zhou, Xuejun Yan, Hecheng Zhu, Zhaoqi Xin, Jin Zhao, Wenyue Shen, Wen Yin, Youwei Guo, Hongjuan Xu, Ming Fei Zhao et al. · 2021 · Theranostics
  51. Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics
    Thijs Van de Vyver, Stefaan C. De Smedt, Koen Raemdonck · 2021 · Advanced Drug Delivery Reviews
  52. Robust, Durable Gene Activation In Vivo via mRNA-Encoded Activators
    Jared P. Beyersdorf, Swapnil Subhash Bawage, Nahid Iglesias, Hannah E. Peck, Ryan A. Hobbs, James A. Wroe, Chiara Zurla, Charles A. Gersbach, Philip J. Santangelo · 2022 · ACS Nano
  53. New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review
    Marie‐Therese Holzer, Martin Krusche, Nikolas Ruffer, Heinrich Haberstock, Marlene Stephan, Tobias Bruno Huber, Ina Kötter · 2022 · Rheumatology International
  54. Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens
    John C. Kraft, Minh Nguyet Pham, Laila Shehata, Mitch Brinkkemper, Seyhan Boyoglu-Barnum, Kaitlin R. Sprouse, Alexandra C. Walls, Suna Cheng, Mike Murphy, Deleah Pettie et al. · 2022 · Cell Reports Medicine
  55. High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
    Hanjin Seo, Leekang Jeon, Jaeyeong Kwon, Hyomin Lee · 2023 · Advanced Healthcare Materials
  56. An Overview of Nanoparticle-Based Delivery Platforms for mRNA Vaccines for Treating Cancer
    Lin Yang, Xuehua Chen, Ke Wang, Liang Li, Hongxia Zhang · 2024 · Vaccines
  57. Self-Assembled mRNA-Responsive DNA Nanosphere for Bioimaging and Cancer Therapy in Drug-Resistant Cells
    Yifan Jiang, Xin Xu, Xiao Jun Fang, Shuxian Cai, Min Wang, Chao Xing, Chunhua Lü, Huanghao Yang · 2020 · Analytical Chemistry
  58. Therapeutic vaccines for colorectal cancer: The progress and future prospect
    Mina Shahnazari, Pouria Samadi, Mona Pourjafar, Akram Jalali · 2020 · International Immunopharmacology
  59. Polymeric materials for immune engineering: Molecular interaction to biomaterial design
    Shreya S. Soni, Christopher B. Rodell · 2021 · Acta Biomaterialia
  60. Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape
    André E. Nel, Jeff F. Miller · 2021 · ACS Nano
  61. Revisiting the role of pulsed electric fields in overcoming the barriers to in vivo gene electrotransfer
    Shaurya Sachdev, Tjaša Potočnik, Lea Rems, Damijan Miklavčič A · 2021 · Bioelectrochemistry
  62. On the road to ending the COVID-19 pandemic: Are we there yet?
    J. Case, Emma S. Winkler, J. Errico, Michael S. Diamond · 2021 · Virology
  63. COVID-19 vaccines in pregnancy
    Marta Coelho Nunes, Shabir Ahmed Madhi · 2022 · Trends in Molecular Medicine
  64. The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
    Yelee Kim, Hyo‐Suk Kim, Eun Hye Kim, Hochung Jang, Yeongji Jang, Sung-Gil Chi, Yoosoo Yang, Sun Hwa Kim · 2022 · Pharmaceutics
  65. Analysis of therapeutic nucleic acids by capillary electrophoresis
    Wei, Bingchuan, Goyon, Alexandre, Zhang, Kelly · 2022 · Journal of Pharmaceutical and Biomedical Analysis
  66. Current Vaccine Platforms in Enhancing T-Cell Response
    Takehiro Ura, Masaki Takeuchi, Tatsukata Kawagoe, Nobuhisa Mizuki, Kenji Okuda, Masaru Shimada · 2022 · Vaccines
  67. mRNA vaccines in the prevention and treatment of diseases
    Yangzhuo Gu, Jiangyao Duan, Na Yang, Yuxin Yang, Xing Zhao · 2022 · MedComm
  68. The journey of a lifetime — development of Pfizer’s COVID-19 vaccine
    Chelsea R. Thorn, Divya Sharma, R. Combs, Sonal V. Bhujbal, Jennifer Romine, Xiaolu Zheng, K. Sunasara, A. Badkar · 2022 · Current Opinion in Biotechnology
  69. Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy
    Paolo Morfino, Alberto Aimo, Vincenzo Castiglione, Carolina Gálvez‐Montón, Michele Emdin, Antoni Bayés‐Genís · 2022 · Heart Failure Reviews
  70. An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations
    Mona Sadat Mirtaleb, Reza Falak, Jalal Heshmatnia, Behnaz Bakhshandeh, Ramezan Ali Taheri, Hoorieh Soleimanjahi, Reza Zolfaghari Emameh · 2023 · International Immunopharmacology
  71. Overcoming biological barriers by virus-like drug particles for drug delivery
    Yuling Chen, Chun‐Jie Bao, Jia‐Lun Duan, Ying Xie, Wan-Liang Lü · 2023 · Advanced Drug Delivery Reviews
  72. Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines
    Yeung Wu, Sinuo Yu, Irene de Lázaro · 2024 · Nanoscale
  73. Nanomedicines for the Delivery of Biologics
    John C. Wahlich, Arpan S. Desai, Francesca Greco, Kathryn J. Hill, Arwyn Tomos Jones, Randall J. Mrsny, Gianfranco Pasut, Yvonne Perrie, F. Philipp Seib, Leonard William Seymour et al. · 2019 · Pharmaceutics
  74. Acquired tick resistance: The trail is hot
    Sukanya Narasimhan, Cheyne Kurokawa, Melody DeBlasio, Jaqueline Matias, Andaleeb Sajid, Utpal Pal, Geoffrey E. Lynn, Erol Fikrig · 2020 · Parasite Immunology
  75. Nano-Microparticle Platforms in Developing Next-Generation Vaccines
    Giuseppe Cappellano, Hugo Abreu, Chiara Casale, Umberto Dianzani, Annalisa Chiocchetti · 2021 · Vaccines
  76. Current and prospective computational approaches and challenges for developing COVID-19 vaccines
    Woochang Hwang, Winnie Lei, Nicholas M. Katritsis, Méabh MacMahon, Kathryn L. Chapman, Namshik Han · 2021 · Advanced Drug Delivery Reviews
  77. An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
    Alejandro Pascual‐Iglesias, Javier Cantón, Ana Maria Ortega‐Prieto, Jose M. Jiménez-Guardeño, José Ángel Regla-Nava · 2021 · Pathogens
  78. COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns
    Maria L. Ekstrand, Elsa Heylen, Monica Gandhi, Wayne T. Steward, Matilda Pereira, Krishnamachari Srinivasan · 2021 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  79. Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application
    Ana Sara Cordeiro, Yogita Patil‐Sen, Maitreyi Shivkumar, Ronak Patel, Abdulwahhab Khedr, Mohamed A. Elsawy · 2021 · Pharmaceutics
  80. Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2
    Eli Magen, Avi Yakov, Ilan Green, Ariel Israel, Shlomo Vinker, Eugene Merzon · 2022 · Allergy and Asthma Proceedings
  81. RGD peptide-based lipids for targeted mRNA delivery and gene editing applications
    Jingya Qin, Lulu Xue, Ningqiang Gong, Hanwen Zhang, Sarah J. Shepherd, Rebecca M. Haley, Kelsey L. Swingle, Michael J. Mitchell · 2022 · RSC Advances
  82. Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery
    Vartika Srivastava, Kripa N. Nand, Aijaz Ahmad, Ravinder Kumar · 2023 · Vaccines
  83. Cargo-selective and adaptive delivery of nucleic acid therapeutics by bola-amphiphilic dendrimers
    Jiaxuan Chen, Dandan Zhu, Baoping Lian, Kangjie Shi, Peng Chen, Ying Li, Wenyi Lin, Ling Ding, Qiulin Long, Yang Wang et al. · 2023 · Proceedings of the National Academy of Sciences
  84. Messenger RNA chromatographic purification: advances and challenges
    Feng Xue, Zhiguo G. Su, Yuan Cheng, Guanghui Ma, Songping Zhang · 2023 · Journal of Chromatography A
  85. Enhanced Local Delivery of Engineered IL-2 mRNA by Porous Silica Nanoparticles to Promote Effective Antitumor Immunity
    Hojeong Shin, Seounghun Kang, Cheolhee Won, Dal‐Hee Min · 2023 · ACS Nano
  86. A Unified Strategy to Improve Lipid Nanoparticle Mediated mRNA Delivery Using Adenosine Triphosphate
    Yutian Ma, Owen S. Fenton · 2023 · Journal of the American Chemical Society
  87. An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses
    Ryotaro Oyama, Harumichi Ishigame, Hiroki Tanaka, Naho Tateshita, Moeko Itazawa, Ryosuke Imai, Naomasa Nishiumi, Jun-ichi Kishikawa, Takayuki Kato, Jessica Anindita et al. · 2023 · ACS Nano
  88. Exosome-based immunotherapy as an innovative therapeutic approach in melanoma
    Shabnam Babaei, Manouchehr Fadaee, Hajar Abbasi‐Kenarsari, Dariush Shanehbandi, Tohid Kazemi · 2024 · Cell Communication and Signaling
  89. Role of Zika Virus prM Protein in Viral Pathogenicity and Use in Vaccine Development
    Peter Nambala, Wen‐Chi Su · 2018 · Frontiers in Microbiology
  90. mRNA Vaccine Protects against Zika Virus
    Lex G. Medina-Magües, Janina Gergen, Edith Jasny, Benjamin Petsch, Jaime Lopera-Madrid, Emily S. Medina-Magües, Cristhian Salas-Quinchucua, Jorge E. Osorio · 2021 · Vaccines
  91. Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs
    Zhong, Zifu, McCafferty, Séan, Opsomer, Lisa, Wang, Haixiu, Huysmans, Hanne, De Temmerman, Joyca, Lienenklaus, Stefan, Portela Catani, João Paulo, Combes, Francis, Sanders, Niek N. · 2021 · Molecular Therapy
  92. Using Adjuvants to Drive T Cell Responses for Next-Generation Infectious Disease Vaccines
    Rekha R. Rapaka, Alan S. Cross, Monica A. McArthur · 2021 · Vaccines
  93. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine
    Francesca Romana Spinelli, Ennio Giulio Favalli, Cristina Garufi, Martina Cornalba, Serena Colafrancesco, Fabrizio Conti, Roberto Felice Caporali · 2022 · Arthritis Research & Therapy
  94. From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines
    Diana Ofelia Lopez-Cantu, Xichi Wang, Hector Carrasco-Magallanes, Samson Afewerki, Xingcai Zhang, Joseph Vincent Bonventre, Guillermo U. Ruiz‐Esparza · 2022 · Nano-Micro Letters
  95. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development
    Lin Han, Kun Wang, Yuxin Xiong, Liting Zhou, Yong Yang, Shanwei Chen, Peihong Xu, Yujun Zhou, Rui Mao, Guangzhao Lv et al. · 2022 · Frontiers in Immunology
  96. Type I Interferons Promote Germinal Centers Through B Cell Intrinsic Signaling and Dendritic Cell Dependent Th1 and Tfh Cell Lineages
    Madelene W. Dahlgren, Adam W. Plumb, Kristoffer Niss, Katharina Lahl, Søren Brunak, Bengt Johansson‐Lindbom · 2022 · Frontiers in Immunology
  97. The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides
    Miklós Bege, Anikó Borbás · 2022 · Pharmaceuticals
  98. Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination
    Aurélien Sokal, Paul Bastard, Pascal Chappert, Giovanna Barba Spaeth, Slim Fourati, Alexis Vandenberghe, Pauline Lagouge-Roussey, Isabelle Meyts, Adrian Gervais, Magali Bouvier‐Alias et al. · 2022 · The Journal of Experimental Medicine
  99. COVID-induced thyroid autoimmunity
    Alessandro Brancatella, Nicola Viola, Ferruccio Santini, Francesco Latrofa · 2023 · Best Practice & Research Clinical Endocrinology & Metabolism
  100. The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics
    Albert Radikovich Muslimov, Valeriy Tereshchenko, Daniil Shevyrev, Anna S. Rogova, Kirill Viktorovich Lepik, Vasiliy V. Reshetnikov, Roman A. Ivanov · 2023 · International Journal of Molecular Sciences